Literature DB >> 12929127

Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells.

Vinod K Asundi1, Robert Erdman, Richard C Stahl, David J Carey.   

Abstract

Schwann cells transiently express the transmembrane heparan sulfate proteoglycan syndecan-3 during the late embryonic and early postnatal periods of peripheral nerve development. Neonatal rat Schwann cells released soluble syndecan-3 into the culture medium by a process that was blocked by inhibition of endogenous matrix metalloproteinase activity. When Schwann cells were plated on a substratum that binds syndecan-3, the released proteoglycan bound to the substratum adjacent to the cell border. Membrane-anchored syndecan-3 was concentrated in actin-containing filopodia that projected from the lateral edges of the Schwann cell membrane. Membrane shedding was specific for syndecan-3 and was not observed for the related proteoglycan syndecan-1. Analysis of Schwann cells transfected with wild-type and chimeric syndecan-1 and syndecan-3 cDNAs revealed that membrane shedding was a property of the syndecan-3 ectodomain. Inhibition of syndecan-3 release significantly enhanced Schwann cell adhesion and process extension on dishes coated with the non-collagenous N-terminal domain of alpha4(V) collagen, which binds syndecan-3 and mediates heparan sulfate-dependent Schwann cell adhesion. Matrix metalloproteinase-dependent syndecan-3 shedding was also observed in newborn rat peripheral nerve tissue. Syndecan-3 shedding in peripheral nerve tissue was age specific, and was not observed during later stages of postnatal nerve development. These results demonstrate that Schwann cell syndecan-3 is subject to matrix metalloproteinase-dependent membrane processing, which modulates the biological function of this proteoglycan. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929127     DOI: 10.1002/jnr.10699

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

Review 1.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

2.  Syndecan-3 contributes to the regulation of the microenvironment at the node of Ranvier following end-to‑side neurorrhaphy: sodium image analysis.

Authors:  Chiung-Hui Liu; Yu-Chen Kuo; Che-Yu Wang; Chao-Chun Hsu; Ying-Jui Ho; Yun-Chi Chiang; Fu-Der Mai; Wei-Jhih Lin; Wen-Chieh Liao
Journal:  Histochem Cell Biol       Date:  2020-11-10       Impact factor: 4.304

3.  Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.

Authors:  Kan Ding; Martha Lopez-Burks; José Antonio Sánchez-Duran; Murray Korc; Arthur D Lander
Journal:  J Cell Biol       Date:  2005-11-14       Impact factor: 10.539

Review 4.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 5.  Proteolytic modulation of tumor microenvironment signals during cancer progression.

Authors:  Yoshifumi Itoh
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

6.  Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.

Authors:  Jennifer R Higginson; Sophie M Thompson; Alessandra Santos-Silva; Scott E Guimond; Jeremy E Turnbull; Susan C Barnett
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

7.  Binding of Y-P30 to syndecan 2/3 regulates the nuclear localization of CASK.

Authors:  Peter Landgraf; Marina Mikhaylova; Tamar Macharadze; Corinna Borutzki; Ana-Claudia Zenclussen; Petra Wahle; Michael R Kreutz
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 8.  Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation.

Authors:  Daisuke Ibi; Kiyofumi Yamada
Journal:  Int J Mol Sci       Date:  2015-11-27       Impact factor: 5.923

9.  Extended disorder at the cell surface: The conformational landscape of the ectodomains of syndecans.

Authors:  Frank Gondelaud; Mathilde Bouakil; Aurélien Le Fèvre; Adriana Erica Miele; Fabien Chirot; Bertrand Duclos; Adam Liwo; Sylvie Ricard-Blum
Journal:  Matrix Biol Plus       Date:  2021-07-19

10.  Axonal debris accumulates in corneal epithelial cells after intraepithelial corneal nerves are damaged: A focused Ion Beam Scanning Electron Microscopy (FIB-SEM) study.

Authors:  Paola Parlanti; Sonali Pal-Ghosh; Alexa Williams; Gauri Tadvalkar; Anastas Popratiloff; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2020-03-21       Impact factor: 3.467

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.